Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:32:351-380.
doi: 10.1007/7854_2016_15.

NPS: Medical Consequences Associated with Their Intake

Affiliations
Review

NPS: Medical Consequences Associated with Their Intake

Fabrizio Schifano et al. Curr Top Behav Neurosci. 2017.

Abstract

Over the last decade, the 'traditional' drug scene has been supplemented - but not replaced - by the emergence of a range of novel psychoactive substances (NPS), which are either newly created or existing drugs, including medications, now being used in novel ways. By the end of 2014, in excess of 500 NPS had been reported by a large number of countries in the world. Most recent data show, however, that synthetic cathinones, synthetic cannabinoids, and psychedelics/phenethylamines account for the largest number of NPS.The present chapter aims at providing an overview of the clinical and pharmacological issues relating to these most popular NPS categories. Given the vast range of medical and psychopathological issues associated with the molecules here described, it is crucial for health professionals to be aware of the effects and toxicity of NPS. A general overview of the acute management of NPS adverse events is provided as well, although further studies are required to identify a range of evidence-based, index molecule-focused, treatment strategies. The rapid pace of change in the NPS online market constitutes a major challenge to the provision of current and reliable scientific knowledge on these substances.

Keywords: Drug misuse; Hallucinogenic drugs; Hallucinogens; Novel psychoactive substances; Phenethylamines; Psychiatric disturbances; Synthetic cannabimimetics; Synthetic cathinones.

PubMed Disclaimer

Similar articles

Cited by

References

    1. UNODC (United Nations Office on Drugs and Crime) (2015) World Drug Report. https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf . Accessed 30 Nov 2015
    1. EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2015) New psychoactive substances in Europe - an update from the EU Early Warning System. Publications Office of the European Union, Luxembourg. http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances . Accessed 15 Nov 2015
    1. EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2015) Synthetic cannabinoids in Europe. http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids . Accessed 29 Nov 2015
    1. Daly M (2013) Streets legal. Druglink 28:17
    1. Shlosberg D, Zalsman G, Shoval G (2014) Emerging issues in the relationship between adolescent substance use and suicidal behavior. Isr J Psychiatry Relat Sci 51:262–267 - PubMed

Publication types

MeSH terms

LinkOut - more resources